Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has submitted a compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended 31 December 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Pvt Ltd (formerly Link Intime), on 1 January 2026. It confirms that all share certificates received from depository participants for dematerialisation during the quarter were properly verified, processed, and confirmed to the depositories, with the original certificates mutilated and cancelled. The company secretary, Priyanka Sharma, signed the submission dated 13 January 2026. This is a routine quarterly regulatory filing required of all listed companies.
No material impact on shareholders or stock price — this is a standard procedural filing confirming that share dematerialisation activities during the October–December 2025 quarter were completed in line with SEBI rules. Investors should read this as an administrative update, not a business event.